Por favor, use este identificador para citar o enlazar este ítem:
https://doi.org/10.1080/22221751.2022.2098059
![](/digitum/image/email_logo.png)
![](/digitum/image/logo-facebook.png)
Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Sánchez Barrueco, Álvaro | - |
dc.contributor.author | Mateos-Moreno, Maria Victoria | - |
dc.contributor.author | Martínez- Beneyto, Yolanda | - |
dc.contributor.author | García-Vázquez, Elisa | - |
dc.contributor.author | Campos González, Alfonso | - |
dc.contributor.author | Zapardiel Ferrero, Javier | - |
dc.contributor.author | Bogoya Castaño, Abel | - |
dc.contributor.author | Alcalá Rueda, Ignacio | - |
dc.contributor.author | Villacampa Aubá, José Miguel | - |
dc.contributor.author | Cenjor Español, Carlos | - |
dc.contributor.author | Moreno-Parrado, Laura | - |
dc.contributor.author | Ausina- Márquez, Verónica | - |
dc.contributor.author | García-Esteban, Sandra | - |
dc.contributor.author | Artacho, Alejandro | - |
dc.contributor.author | López- Labrador, F. Xavier | - |
dc.contributor.author | Mira, Alex | - |
dc.contributor.author | Ferrer, María D. | - |
dc.contributor.other | Facultades, Departamentos, Servicios y Escuelas::Departamentos de la UMU::Medicina Interna | es |
dc.date.accessioned | 2024-06-20T08:27:06Z | - |
dc.date.available | 2024-06-20T08:27:06Z | - |
dc.date.issued | 2022-07-27 | - |
dc.identifier.citation | Emerging Microbes & Infections. 2022, Vol. 11(1): 1833-1842 | es |
dc.identifier.isbn | Electronic: 2222-1751 | - |
dc.identifier.uri | http://hdl.handle.net/10201/142485 | - |
dc.description | ©2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ . This document is the Accepted, version of a Published Work that appeared in final form in Emerging Microbes & Infections. To access the final edited and published work see https://doi.org/10.1080/22221751.2022.2098059 | es |
dc.description.abstract | Background: In vitro studies have shown that several oral antiseptics have virucidal activity against SARS-CoV-2. Thus, mouthwashes have been proposed as an easy to implement strategy to reduce viral transmission. However, there are no data measuring SARS-CoV-2 viability after mouthwashes in vivo. Methods: In this randomized double-blind, five-parallel-group, placebo-controlled clinical trial, SARS-CoV-2 salivary viral load (by quantitative PCR) and its infectious capacity (incubating saliva in cell cultures) have been evaluated before and after four different antiseptic mouthwashes and placebo in 54 COVID-19 patients. Results: Contrary to in vitro evidence, salivary viral load was not affected by any of the four tested mouthwashes. Viral culture indicated that cetylpyridinium chloride (CPC) significantly reduced viral infectivity, but only at one-hour post-mouthwash. Conclusion: These results indicate that some of the mouthwashes currently used to reduce viral infectivity are not efficient in vivo and, furthermore, that this effect is not immediate, generating a false sense of security. | es |
dc.format | application/pdf | es |
dc.format.extent | 23 | es |
dc.language | eng | es |
dc.publisher | Taylor and Francis Group | es |
dc.relation | FISABIO-Public Health BSL-3, supported by the Conselleria de Sanitat, Generalitat Valenciana and by the European Union Regional Development Fund. Biobank Network of the Region of Murcia, BIOBANC-MUR (B.0000859), supported by the Instituto de Salud Carlos III (proyecto PT20/00109), by Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB) and by Conserjería de Salud de la Comunidad Autónoma de la Región de Murcia | es |
dc.rights | info:eu-repo/semantics/openAccess | es |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | SARS-CoV-2 | es |
dc.subject | Saliva | es |
dc.subject | COVID-19 | es |
dc.subject | Infectivity | es |
dc.subject | Mouthwas | es |
dc.title | Effect of oral antiseptics in reducing SARS-CoV-2 infectivity: Evidence from a randomized double- blind clinical trial | es |
dc.type | info:eu-repo/semantics/article | es |
dc.relation.publisherversion | https://www.tandfonline.com/doi/full/10.1080/22221751.2022.2098059 | es |
dc.identifier.doi | https://doi.org/10.1080/22221751.2022.2098059 | - |
Aparece en las colecciones: | Artículos: Medicina |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Effect of Oral Antiseptics....pdf | 1,46 MB | Adobe PDF | ![]() Visualizar/Abrir |
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons